IGF1 and colorectal carcinoma: Although at the doses used (84 mg daily/8 weeks), isoflavone supplementation did not influence circulating IGF concentrations in men at a high risk of CRC, a relative decrease in serum total IGF-I concentrations was found in equol producers only.